Harry Kovelman - 11 Mar 2025 Form 4 Insider Report for MYOMO, INC. (MYO)

Role
Chief Medical Officer
Signature
/s/ David A. Henry, Attorney-in-Fact
Issuer symbol
MYO
Transactions as of
11 Mar 2025
Net transactions value
-$172,827
Form type
4
Filing time
13 Mar 2025, 16:41:37 UTC
Previous filing
05 Nov 2024
Next filing
06 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYO Common Stock Award $0 +3,553 +2.9% $0.000000 127,973 11 Mar 2025 Direct F1
transaction MYO Common Stock Sale $165,018 -30,000 -23% $5.50 97,973 12 Mar 2025 Direct F2, F3
transaction MYO Common Stock Tax liability $7,809 -1,496 -1.5% $5.22 96,477 13 Mar 2025 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of restricted stock units ("RSU's") on March 11, 2025 under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's became fully vested on the grant date.
F2 Represents sale of shares in an open market transaction
F3 Represents average sales price. Transactions were completed in multiple lots at prices ranging from $5.50 to $5.53 per share. Reporting Party agrees to provide details of the trades to the SEC upon request.
F4 Shares sold on March 13, 2025 solely to cover income taxes on a vesting of restricted stock units on March 11, 2025, pursuant to an irrevocable election made by the Reporting Party on March 11, 2025.